Episode 59: Ipatercertib in biomarker positive castrate resistant prostate cancer

The Uromigos - Podcast autorstwa The Uromigos

Podcast artwork

Chris Sweeney (last author) discusses the ATK inhibitor Ipatercertib in pTEN altered CRPC. A positive R3 trial in the ESMO plenary session. 

Visit the podcast's native language site